26 May 2013
Keywords: Pancreatic cancer, Market, Clinical failures, Gemzar, Eli Lilly, GlobalData
Article | 03 June 2010
The pancreatic cancer market has fewer competitors than most cancer markets, despite being one of the most challenging forms of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 June 2010
2 June 2010
24 May 2013
© 2013 thepharmaletter.com